Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Pharming Group NV (PHGUF) had Debt to Equity Ratio of 0.51 for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$92.67M |
|
$2.84M |
|
$12.19M |
|
$80.47M |
|
$85.98M |
|
$6.68M |
|
$0.04M |
|
$6.72M |
|
$6.72M |
|
$2.84M |
|
$2.84M |
|
$2.84M |
|
$2.84M |
|
$6.68M |
|
$14.38M |
|
671.35M |
|
785.41M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$278.44M |
|
$7.75M |
|
$121.56M |
|
$399.99M |
|
$73.80M |
|
$105.12M |
|
$105.12M |
|
$178.92M |
|
$221.06M |
|
$160.02M |
|
$221.06M |
|
680.31M |
|
| Cash Flow Statement Financials | |
$-1.79M |
|
$31.62M |
|
$-34.41M |
|
$61.74M |
|
$54.94M |
|
$-6.80M |
|
$11.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.77 |
|
-- |
|
-- |
|
0.32 |
|
|
Debt to Equity Ratio |
0.51 |
86.84% |
|
7.21% |
|
7.21% |
|
-- |
|
7.25% |
|
3.07% |
|
$-2.58M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.22 |
|
1.69 |
|
53.25 |
|
1.29% |
|
1.78% |
|
0.71% |
|
0.87% |
|
$0.32 |
|
$-0.00 |
|
$-0.00 |
|